Evonik stock has results on November 3, 2026, slightly lower pre-market
Published on 10/22/2026 at 08:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly reporting date ahead
- Evonik's investor calendar schedules the third-quarter report for November 3, 2026.
- Evonik develops and manufactures products for pharmaceutical and biotech customers.
- Evonik stock trades pre-market at EUR 20.83 at 8:10 a.m. CEST at Lang & Schwarz on October 22, 2026, 0.33 percent below the Xetra close of October 21, 2026.
Evonik's investor-relations calendar schedules its report on third-quarter 2026 business for November 3, 2026, according to Evonik. Evonik stock trades pre-market at EUR 20.83 at 8:10 a.m. CEST at Lang & Schwarz on October 22, 2026, 0.33 percent below the Xetra close of October 21, 2026 (EUR 20.90).
Quarterly report on the calendar
The company has scheduled an online presentation on November 3, 2026, for its third-quarter 2026 reporting. The date is listed in Evonik's investor-relations calendar.
Ahead of the Xetra open
The pre-market indication is EUR 0.07 below the Xetra close. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Evonik stock.
Evonik's business and the day
Evonik develops and manufactures products and production capacity for pharmaceutical and biotech customers, including lipid-based drug-delivery applications, as described by Evonik. The next scheduled company date is November 3, 2026. Market context: Market report DAX.
